Ezetimibe and Simvastatin

NDC 59651-835 · Aurobindo Pharma Limited

Generic nameEzetimibe and Simvastatin

Dosage formTABLET

RouteORAL

Active ingredient(s)EZETIMIBE, SIMVASTATIN

Strength10; 10 mg/1; mg/1

Pharmacologic classDecreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC], HMG-CoA Reductase Inhibitor [EPC], Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]

Marketing categoryANDA

Packages

59651-835-30 — 30 TABLET in 1 BOTTLE (59651-835-30)

59651-835-90 — 90 TABLET in 1 BOTTLE (59651-835-90)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

51655-459 — SIMVASTATIN, 51655-598 — simvastatin, 51655-643 — simvastatin, 51655-841 — Simvastatin, 51660-200 — Ezetimibe, 53401-013 — Simvastatin, 53401-018 — Simvastatin, 53401-026 — Simvastatin, 55154-4782 — Simvastatin, 59651-052 — Ezetimibe, 59651-836 — Ezetimibe and Simvastatin, 59651-837 — Ezetimibe and Simvastatin, 59651-838 — Ezetimibe and Simvastatin, 60429-982 — Ezetimibe, 60687-210 — Simvastatin, 60687-373 — Ezetimibe, 60760-579 — SIMVASTATIN, 60760-580 — SIMVASTATIN, 60760-585 — SIMVASTATIN, 63187-075 — simvastatin, +214 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels